medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2014, Number 1

<< Back Next >>

Rev Esp Med Quir 2014; 19 (1)

Hantavirus pulmonary syndrome, a threat in Mexico

Moreno SHN, Rangel GSI, Thompson BMR, Merino GJL, Lara LM, Piña LC, Rosas SG, Morán ME, Rodríguez GJ, Calderón RG, Aguilar SJÁ, González BJA

Language: Spanish
References: 35
Page: 96-103
PDF size: 546.13 Kb.


ABSTRACT

In the last years, more than 30 agents that cause infectious diseases have been identified. Some of them are responsible for emerging diseases, potentially deadly to humans, such as the human immunodeficiency Virus (HIV), Ebola, Marburg, and hantavirus. Some of these viruses are associated with rodents, which act as reservoirs, particularly for the members of two negative-sense RNA viruses: arenaviruses and hantaviruses, both with a worldwide distribution. Hantaviruses are the causal agent for the Hantavirus Pulmonary Syndrome (HPS), which is characterized by cough, cardiorespiratory damage, fever, chills, nasal discharge, muscle pain, headache, respiratory distress, and thrombocytopenia. Rodents from the Sigmodontinae y Neotominae families are the main reservoirs and can transmit the infection by contact with infected tissues, urine, feces, and/or saliva. In México, there are reports about rodents seropositive to hantavirus in lands of Colima (ORO virus), Morelos, and Guerrero (Montano, Carrizal and Huitzilac viruses). In the USA, hantavirus infections in humans have been reported (“Without name” variant). In Mexico there is serological evidence of the infection in patients from Yucatan; however, the diagnosis using molecular detection techniques has not been performed, making it possible that the HPS is being mistaken with other diagnosis, such as influenza.


REFERENCES

  1. Zhang YZ, Zou Y, Fu ZF y Plyusnin A. Hantavirus infections in humans and animals, China. Emerg Infect Dis 2010;16:1195-1203.

  2. Lednicky JA. Hantaviruses. a short review. Arch Pathol Lab Med 2003;127:30-35.

  3. Mir MA. Hantaviruses. Clin Lab Med 2010;30:67-91.

  4. Schmaljohn C y Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis 1997;3:95-104.

  5. Jonsson CB, Hooper J, Mertz G. Treatment of hantavirus pulmonary syndrome. Antiviral Res 2008;78:162-169.

  6. Hall PR, Leitão A, Ye C, et al. Small molecule inhibitors of hantavirus infection. Bioorg Med Chem Lett 2010;20:7085- 7091.

  7. Mackow ER y Gavrilovskaya IN. Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol 2001;256:91-115.

  8. Vaheri A, Strandin T, Hepojoki J, et al. Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol 2013;11:539-50.

  9. Muranyi W, Bahr U, Zeier M, van der Woude FJ. Hantavirus infection. J Am Soc Nephrol 2005;16:3669-3679.

  10. Handke W, Oelschlegel R, Franke R, Krüger DH, Rang A. Hantaan virus triggers TLR3-dependent innate immune responses. J Immunol 2009;182:2849-2858.

  11. MacNeil A, Nichol ST, Spiropoulou CF. Hantavirus pulmonary syndrome. Virus Res 2011;162:138-147.

  12. Krüger DH, Schönrich G, Klempa B. Human pathogenic hantavirus and prevention of infection. Hum Vaccin 2012;7:685-693.

  13. Zeier M, Handermann M, Bahr U, et al. New ecological aspects of Hantavirus infection: A change of a paradigm and a challenge of prevention- A review. Virus Genes 2005;30:157-180.

  14. Young JC, Hansen GR, Graves TK, et al. The incubation period of hantavirus pulmonary syndrome. Am J Trop Med Hyg 2000;62:714-717.

  15. Stelzel W. Hantavirus pulmonary syndrome: epidemiology, prevention, and case presentation of a new viral strain. Nurse Pract 1996;21:89-90, 93, 96 passim.

  16. Navarrete CM, Saldias NF, Mancilla R, Zaror R, Ferres M. Evidencia clínico epidemiológica de la existencia de síndrome pulmonar por hantavirus en Valdivia-Chile desde 1993. Rev Chil Infectol 2000;17:233-240.

  17. CDC. Hantavirus. Agosto 2013. Disponible en: www.cdc. gov/hantavirus/hps/diagnosis.html.

  18. Castillo HC, Cea BX, Navarrete CM y Ossa AG. Neumonías atípicas graves y diagnóstico diferencial con el síndrome cardiopulmonar por hantavirus. Experiencia clínica en tres casos confirmados. Rev Chil Enferm Respir 2003;19:101-108.

  19. Vaquero M. Neumonías intersticiales idiopáticas: criterios actuales para su clasificación. 7º Congreso Virtual Hispanoamericano de Anatomía Patológica. 2005.

  20. Tsukada H, Ying X, Fu C, Ishikawa S, et al. Ligation of endothelial alpha v beta 3 integrin increases capillary hydraulic conductivity of rat lung. Circ Res 1995;77:651-659.

  21. Bossi F, Fischetti F, Pellis V, et al. Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. J Immunol 2004;173:6921-6927.

  22. Dearing MD, Dizney L. Ecology of hantavirus in a changing world. Ann N Y Acad Sci. 2010;1195:99-112.

  23. Sánchez-Cordero V, Peterson A, Martínez-Meyer E. y Flores R. Distribución de roedores reservorios del virus causante del síndrome pulmonar por Hantavirus y regiones de posible riesgo en México. Acta Zoológica Mexicana (n.s.) 2005;21:79-91.

  24. Jay M, Ascher MS, Chomel BB, et al. Seroepidemiologic studies of hantavirus infection among wild rodents in California. Emerg Infect Dis1997;3:183-190.

  25. Hjelle B, Glass GE. Outbreak of hantavirus infection in the Four Corners region of the United States in the wake of the 1997-1998 El Nino-southern oscillation. J Infect Dis 2010;181:1569-1573.

  26. Marr JS, Kiracofe JB. Was the huey cocoliztli a haemorrhagic fever? Med Hist 2000;44:341–362.

  27. Hjelle B, Anderson B, Torrez-Martinez N, Song W, Gannon WL, Yates TL. Prevalence and geographic genetic variation of hantaviruses of New World harvest mice (Reithrodontomys): identification of a divergent genotype from a Costa Rican Reithrodontomys mexicanus. Virology 1995;207:452.

  28. [28]. Chu YK, Owen RD, Sánchez-Hernández C, Romero- Almaraz M. de L. y Jonsson CB. Genetic characterization and phylogeny of a Hantavirus from Western Mexico. Virus Res 2008;131:180-188.

  29. Mantooth SJ, Milazzo ML, Bradley RD, et al. Geographical distribution of rodent-associated hantaviruses in Texas. J Vector Ecol 2001;26:7-14.

  30. Suzán G, Ceballos G, Mills J. Ksiazek T y YatesT.. Serologic evidence of hantavirus infection in Sigmodontine rodents in Central Mexico. J Wildl Dis 2001;37:391-393.

  31. Castro-Arellano I, Suzán G, León RF, Jiménez RM, Lacher TE Jr. Survey for antibody to Hantaviruses in Tamaulipas, Mexico. J Wildl Dis 2009;45:207-212.

  32. Milazzo M, Cajimat M, Romo H, Estrada-Franco J, et al. Geographic Distribution of Hantaviruses Associated with Neotomine and Sigmodontine Rodents, Mexico. Emerg Infect Dis 2012;18: 571-576.

  33. Kariwa H, Yoshida H, Sánchez-Hernández C, Romero- Almaraz MD, Almazán-Catalán JA, Ramos C, et al. Genetic diversity of hantaviruses in Mexico: Identification of three novel hantaviruses from Neotominae rodents. Virus Res 2012;163:486-494.

  34. Flores-León R. Los Hantavirus: un nuevo desafío para la epidemiología. Laboratorio de Hantavirus y Virus Hemorrágicos/ InDRE/ SSA.

  35. Vado-Solís, Pérez-Osorio, Lara-Lara y col. Evidencia serológica de infección por Hantavirus en población humana del estado de Yucatán, México. Rev Biomed 2003;14:221-225.




2020     |     www.medigraphic.com